Lepromatous leprosy in an HIV-positive patient in Spain
Jc Moreno-Giménez
Department of Medical-Surgical Dermatology and Venereology, Reina Sofia University Hospital Medical School. Córdoba, Spain,
Corresponding author, Dermatology, Av. Menéndez Pidal s/n, 14004 Córdoba, Spain, E-mail: [email protected]
Search for more papers by this authorF Valverde
Department of Medical-Surgical Dermatology and Venereology, Reina Sofia University Hospital Medical School. Córdoba, Spain,
Search for more papers by this authorJj Rios
Department of Dermatopathology, Virgen Macarena University Hospital, Seville, Spain,
Search for more papers by this authorF Lopez Rubio
Dermatopathology, Reina Sofia University Hospital. Córdoba, Spain.
Search for more papers by this authorJc Moreno-Giménez
Department of Medical-Surgical Dermatology and Venereology, Reina Sofia University Hospital Medical School. Córdoba, Spain,
Corresponding author, Dermatology, Av. Menéndez Pidal s/n, 14004 Córdoba, Spain, E-mail: [email protected]
Search for more papers by this authorF Valverde
Department of Medical-Surgical Dermatology and Venereology, Reina Sofia University Hospital Medical School. Córdoba, Spain,
Search for more papers by this authorJj Rios
Department of Dermatopathology, Virgen Macarena University Hospital, Seville, Spain,
Search for more papers by this authorF Lopez Rubio
Dermatopathology, Reina Sofia University Hospital. Córdoba, Spain.
Search for more papers by this authorAbstract
We report a 35-year-old HIV-positive male affected by lepromatous leprosy which, to our knowledge, is the first case of its kind in Spain. The relationship between the two conditions is discussed.
References
- 1 Alonso E & Jareno P. Epidemias y sociedad desde la Lepra al SIDA. Med Clin (Barc) 1997; 109: 177–180.
- 2 Jansen F, Wallech D & Khounong MA et al. Association de maladie de Hansen et d’infection par le virus de l’immodeficiency humaine: deux observations. Press Med 1988; 17: 1652–1653.
- 3 Kennedy C, Lien R & Stotz E et al. Leprosy and human immunodeficiency infection: a closer look at the lesions. Int J Dermatol 1990; 29: 139–140.
- 4 Lamfers EJP, Batiaans AM & Mravunac M et al. Leprosy in the acquired immunodeficiency syndrome (Letter). Ann Intern Med 1987; 107: 111–112.
- 5 Goodless DR, Viciana AL & Pardo RJ et al. Borderline tuberculoid Hansen’s disease in AIDS. J Am Acad Dermatol 1994; 30: 866–869.
- 6 Turk JL & Rees RJW. AIDS and leprosy. Lepr Rev 1988; 59: 639–644.
- 7 Andrade VL, Moreira T & Regazzi JC et al. Prevalence of HIV1 in leprosy patients in Rio de Janeiro, Brazil. Acta Leprol 1997; 10: 159–163.
- 8 Machado P, David Y & Pedroso C et al. Leprosy HIV Infection Bahia, Brazil. Int J Lepr Other Mycobact Dis 1998; 66: 227–229.
- 9 Awofeso N. AIDS and tuberculosis/leprosy in Nigeria: the urbanisation factor. Acta Leprol 1995; 9: 149–151.
- 10 Sterne JA, Turner AC & Fine PEM et al. Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic. J Infect Dis 1995; 172: 543–546.
- 11 Pönnighaus JM, Mwanjasi LJ & Fine PEM et al. Is HIV infection a risk factor for leprosy? Int J Lepr Mycobact Dis 1991; 59: 221–228.
- 12 Collins FM. Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev 1989; 2: 360–377.
- 13 Meeran K. Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia. Br Med J 1989; 298: 364–365.
- 14 Baskin GB, Gormus BJ & Martin LN et al. Pathology of dual Mycobacterium leprae and simian immunodeficiency virus infection in rhesus monkeys. Int J Lepr Mycobact Dis 1990; 58: 358–364.
- 15 Leonard G, Sangare A & Verdier M et al. Prevalence of HIV infection among patients with leprosy in African countries and Yemen. J Acq Inm Def Syn 1990; 3: 1109–1113.
- 16 Glaser JB, Lewis WR & Gruber T et al. Prevalence of human T cell lymphotropic virus (HTL) types I and II and human immunodeficiency virus type 1 infections among persons with Hansen’s disease in New York. J Infect Dis 1994; 170: 1007–1009.
- 17 Jacobs M & George S. Skin lesions in HIV-positive and HIV-negative patients in South India. Int J Dermatol 1996; 35: 489–492.
- 18
Kashala O,
Marlink R &
Ilunga M et al.
Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.
J Infect Dis
1994; 169: 236–304.
10.1093/infdis/169.2.296 Google Scholar
- 19 Lucas SB, Fine PEM & Sterne JAC et al. Infection with human immunodeficiency virus type 1 among leprosy patients in Zaire. J Infect Dis 1995; 171: 502–503.
- 20 Patki AH. Some possible interactions of M. lepra and HIV in the peripheral nerves. Int J Lepr Other Mycobact Dis 1991; 59: 331–332.
- 21 Jacob M, George S & Pulimood S et al. Short-term follow-up of patients with multibacillary leprosy and HIV infection. Int J Lepr Other Mycobact Dis 1996; 64: 392–395.
- 22 Said G. Infective neuropathies. Curr Opin Neurol 1994; 398–401.
- 23 Lucas S. Human immunodeficiency virus and leprosy. Lepr Rev 1993; 64: 97–103.
- 24 Faye O, Mahe A & Jamet P et al. Etude anatomopathologique de 5 cas de lepre chez des sujets seropositifs pour le virus de l’immunodeficience humaine (VIH). Acta Leprol 1996; 10: 93–99.
- 25 Vreeburg AE. Clinical observations on leprosy patients with HIV1-infection in Zambia. Lepr Rev 1992; 63: 134–140.
- 26 Schlossberg D. Azithromycin and clarithromycin. Med Clin North Am 1995; 79: 803–815.
Citing Literature
